Est. 2001·3,000+ placements · six offices · four regions
Okta — source image

Image via Fortune

Leadership Changecurated sourcedetected 2026-06-01 · confidence 90%

Okta: Leadership Change

Eric Kelleher, President and COO of Okta, is driving major organizational transformation around AI integration. He's implementing new work design frameworks that treat AI agents as colleagues alongside human workers, requiring managers to budget for 'digital labor' alongside headcount.

Source: Fortune

The leadership read

Leadership transitions often precede broader sales bench-strengthening over the next two quarters.

Market context: MitchelLake's Talent Market Index sits at 98.6 (Neutral), down 1.4 on the prior month; EMEA hiring signal is running steady (-1.1pts).

Okta: 1 signal in the last 90 days — in line with the Sales median of 1 across 25 tracked companies; 0.1% of MitchelLake's EMEA signal flow.

MitchelLake in this thematic

From the MitchelLake archive

More signals across Sales

Leadership Change · EMEA

CGI

Tim Hurlebaus appointed as President and Chief Executive Officer

Leadership Change · EMEA

Trustpilot

Trustpilot appointed John-Paul Savant as non-executive director, former CEO of Auction Technology Group with 20 years digital marketplace experience

Partnership · EMEA

NICE Actimize

NICE Actimize won a major mandate with DNB Bank ASA (Norway's largest financial services group) to deploy X-Sight Enterprise platform for fraud and financial crime detection. Infosys selected as systems integration partner for end-to-end modernization.

Partnership · EMEA

Napier AI

Napier AI partnered with Concentrix to expand its Continuum compliance platform into ANZ markets, leveraging Concentrix's scale and transformation expertise to serve financial services organizations.

Capital Raising · EMEA

Liftoff Mobile

Liftoff Mobile completed IPO on Nasdaq, raising $437 million. CEO Jeremy Bondy led the company public after market stabilization, achieving tenth consecutive quarter of growth. Backed by Blackstone private equity.

Product Launch · EMEA

Novo Nordisk

Novo Nordisk's investigational zenagamtide (once-weekly GLP-1 receptor agonist) demonstrated significant A1C reductions and up to 14.6% weight loss in Phase 2 study of adults with type 2 diabetes, presented at ADA 2026

Weekly briefing

Track companies like Okta — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

Share: WhatsApp · X · Email